SCHEMBL5147424

SCHEMBL5147424

CC1(C)NC(=O)N(CCNc2ncc(F)c(-c3cnc(N(CCCO)c4ccc(F)cc4)s3)n2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PLA2G7 Q13093 1/20 0.35
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2981319 0.87
SCHEMBL5147401 0.87 PLA2G7 (0.39) PLA2G7ALDH1A1
SCHEMBL5148970 0.81 ALDH1A1 (0.34) PLA2G7ALDH1A1
SCHEMBL5181907 0.79 PLA2G7 (0.42) PLA2G7ALDH1A1
SCHEMBL2980582 0.77 CXCR4 (0.35)
SCHEMBL2983306 0.77 SIGMAR1 (0.42)
SCHEMBL2981790 0.77 IKBKB (0.32)
SCHEMBL2985862 0.75
SCHEMBL2977483 0.74 MEN1 (0.31) ALDH1A1
SCHEMBL5149162 0.73 PLA2G7 (0.40) PLA2G7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP claimed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO claimed